Hycult Biotech Inc

Closed
Call
Website
600 W Germantown Pike Ste 400
Plymouth Meeting, PA 19462
+1 (610) 260-1491
https://www.hycultbiotech.com

Hycult Biotech is a leading company specializing in antibodies, assays, and proteins since 1994, with over 30 years of experience in complement research and innate immunity. The company is dedicated to advancing health research by providing reliable products and expert support for a variety of scientific applications.

With a strong commitment to quality, Hycult Biotech focuses on delivering innovative solutions for complement analysis while assisting researchers in achieving accurate results. They offer valuable resources and tools, including the ELISA calculator, designed to enhance the research process and improve overall outcomes.

Generated from the website

Also at this address

Own this business?
See a problem?

You might also like

Myoderm

The Optimal Source
Drugs acting on the respiratory system

Bristol-Myers Squibb

Bristol Myers Squibb is a global biopharmaceutical company dedicated to the discovery, development, and delivery of cutting-edge medicines for individuals facing severe illnesses. The company's unwavering commitment is to provide innovative treatments to patients worldwide, striving to make a meaningful impact on healthcare and improve outcomes for those in need. Generated from their website's infomation
Drugs acting on the respiratory system

Madrigal Pharmaceuticals, Inc

Madrigal Pharmaceuticals, Inc. is a biopharmaceutical company based in Conshohocken, PA, dedicated to developing innovative therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH). Their primary focus lies in creating treatments for adults with NASH exhibiting moderate to advanced liver fibrosis, with ongoing research in Phase 3 trials for those with compensated cirrhosis. With the recent FDA accelerated approval of their first therapy, Madrigal Pharmaceuticals is at the forefront of pioneering treatments for NASH/MASH patients. The company's ambitious research endeavors have resulted in groundbreaking advancements, leading to the development of the first FDA-approved medication specifically tailored to address the challenges faced by patients with NASH. Generated from the website content
United States›Pennsylvania›Plymouth Meeting›Hycult Biotech Inc

Partial Data by Infogroup (c) 2025. All rights reserved.

Partial Data by Foursquare.